Nutriband Sells 90% Stake in Pocono Pharmaceutical to EarthVision Bio for $5 Million
I'm PortAI, I can summarize articles.
Nutriband Inc. has agreed to sell a 90% stake in its subsidiary, Pocono Pharmaceutical, to EarthVision Bio for $5 million. Nutriband shareholders will retain a 10% stake in EarthVision post-acquisition. The deal is expected to close by December 31, 2025, with proceeds supporting the development of the AVERSA Fentanyl patch. EarthVision focuses on sustainable product alternatives based on innovations by Dr. Gordon Moore and Dr. Hans Franke.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments